|
The International Pharmaceutical Federation (FIP) has noted that artificial intelligence (AI) is set to reshape the future of pharmacy, but only if it is integrated responsibly and ethically.
“AI is already transforming how pharmacists work, from automating routine tasks to supporting more advanced clinical decision-making and even accelerating drug discovery. This statement sets out a vision for harnessing the benefits of AI while ensuring that the human judgment, professional autonomy and trusted relationships that define pharmacy are not compromised,” said Lars-Åke Söderlund, FIP vice president, chair of the FIP Technology Advisory Group and co-chair of the policy committee.
The statement highlights how AI technologies (e.g., machine learning, generative AI, robotics and predictive analytics) can boost efficiency, improve medication safety and personalise care. From identifying patients at high risk of non-adherence to providing real-time decision support and optimising chronic disease management, AI can help pharmacists make better-informed decisions that benefit patients and health systems alike.
However, FIP stresses that implementing AI must be governed by robust regulation and clear ethical frameworks. The policy calls for strong safeguards to protect patient privacy and data security, address bias and ensure transparency so that AI tools complement — rather than replace — pharmacists’ expertise.
The statement also underscores the importance of collaboration and education. To make the best use of AI, pharmacists must have the skills and confidence to work with new technologies. This includes embedding AI literacy, data science and digital health competencies into pharmacy education and continuing professional development.
“Pharmacists must remain accountable for patient care and safety. We must be involved in the design, implementation and oversight of AI tools to ensure they are relevant, reliable and truly serve patients’ best interests,” said Dr Whitley Yi, co-chair of the policy committee.
FIP’s recommendations set out clear actions for governments, regulators, technology developers, educators and pharmacy organisations to ensure AI adoption is transparent, equitable and sustainable. The federation also commits to providing leadership and guidance on professional and ethical questions around AI, supporting member organisations with resources and training, and advocating for pharmacists’ vital role in an AI-enabled health system.
|